✦ LIBER ✦

Monitoring versus interim analysis of clinical trials: A perspective from the pharmaceutical industry

✍ Scribed by Gregory G. Enas; Bruce E. Dornseif; Charles B. Sampson; Frank W. Rockhold; Julie Wuu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interim analysis of a randomized clinica

✍ Natalie Porat; Lynn M. Boehnlein; Calisa M. Schouweiler; Jungae Kang; Steven R. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB

Metabolic therapy improves outcomes from

✍ J.Y. Leong*; S. Pepe; A. Calderone; D.S. Esmore; J. van der Merwe; R. Lymbury; A 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 65 KB

A systematic review of the reporting of

✍ Ricardo M Fernandes; Johanna H van der Lee; Martin Offringa 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 452 KB

A randomised clinical trial of intrapart

✍ Diogo Ayres-de-Campos; Austin Ugwumadu; Philip Banfield; Pauline Lynch; Pina Ami 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 173 KB

401: Everolimus Versus Mycophenolatemofe

✍ M. Strueber; F. Stefan; A.R. Simon; G. Warnecke; M. Dierich; A. Haverich; T. Wel 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB

236 INVITED Challenges of drug developme

✍ R. Capdeville 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB